Associate Director, Strategic Options & Assessment
Posted on Apr 6, 2021 by Bristol-Myers Squibb
At Bristol Myers Squibb, we are inspired by a single vision - transforming patients' lives through science. In oncology, hematology, immunology and cardiovascular disease - and one of the most diverse and promising pipelines in the industry - each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
Lead, Strategic Options and Assessment - Heme/CV/Immunoscience/Fibrosis
The Lead, Strategic Options and Assessment (SOA), is responsible for providing insights supporting development of late stage assets and portfolio strategies. This role requires a strategic internal consultant/quantitative analyst who can translate complex technical issues into insights with actionable options and quantifiable tradeoffs, ensuring that pipeline asset decisions maximize overall value, both for patients and for BMS.
SOA is part the R&D arm of the Business Insights and Analytics (BIA) team. Our primary roles are to act as strategy consultants to development teams, and to provide portfolio insights to Therapeutic Area (TA) leads. This position focuses on development decisions and portfolio strategies in one of four TAs (Heme, CV, Immunoscience, or Fibrosis). In addition to performing high-level analytics, the role involves coaching junior analysts, and participating as a subject matter expert on complex issues. The position requires independent and strategic thinking while partnering with our therapeutic area functional leaders (clinical, commercial, biostatistics, regulatory, and others). The successful candidate will also take on significant accountability for representing SOA or BIA R&D on pan-matrix initiatives.
Roles and Responsibilities
Integrate risk assessment, commercial projections, and development costs, in order to value R&D investments for both milestone decisions and for portfolio planning.
Support the valuation of licensing and business development opportunities.
Track pipeline performance against expectations, identify areas for potential intervention, and quantify trade-offs associated with alternative actions.
Quantify technical and regulatory risks using industry-leading methodologies.
Provide a value perspective for cross-functional initiatives such as disease strategy generation, annual budgeting, and long-term strategic planning.
Other duties as assigned.
Required Education and Experience
Bachelors' degree in science, engineering, economics, or other quantitative discipline.
Masters' degree in science, engineering, economics, quantitative social science, or business.
A minimum of 3 years of experience implementing decision-analytic strategy or processes in pharmaceutical/biotech development, with evidence of excellence in that role,
OR 5 years (3 years with PhD) of experience in consulting, forecasting, financial modeling, valuation, and/or decision analysis in a different industry.
Strong skills in financial valuation modeling using spreadsheet software
A deep understanding of clinical development, biostatistics, regulatory issues, and market dynamics in at least one of our key therapeutic areas (hematology, cardiovascular, immunoscience, or fibrosis)
Experience with cell/gene therapy is a plus.
Experience using decision analysis techniques to evaluate investments under uncertainty, including DCF analysis and Monte Carlo simulation